What we treat
Home/Guides & Tips/Menopause/
Menopause

Menopause rage and anger

If you've found yourself losing your temper in ways that feel completely unlike you, you are not alone and you are not losing your mind. What many women experience during perimenopause and menopause isn't ordinary irritability or a character flaw surfacing under pressure. It is a recognised, hormonally-driven neurological phenomenon with a name, a mechanism, and effective treatments.

This article explains what is actually happening in your brain, why the anger often feels disproportionate to the trigger, and what the evidence says about the treatments that genuinely help.

iconUpdated 30 July 2026

Key takeaways

  • Menopause rage is caused by oestrogen's direct effect on the brain's mood-regulation systems, not a personality change or a mental health condition.
  • In a UK cohort study of 978 women at a specialist menopause clinic, irritability was the fourth most prevalent symptom, reported by 90% of participants — ranking above hot flushes.
  • Effective treatments exist, including body identical HRT, CBT, and testosterone therapy. A 2025 study in the British Journal of Psychiatry found a 44.6% mean reduction in mood symptoms with transdermal HRT in 920 women.

You are not losing your mind, and it is not who you are

Before anything else: what you are experiencing is real.

The anger that comes out of nowhere. The disproportionate fury at something small. The guilt afterwards, and the creeping fear that you are becoming someone you don't recognise. These are experiences that millions of women go through during perimenopause and menopause, and they are almost never talked about with the honesty and specificity they deserve.

Many women who search for "menopause rage" do so in private, often after an episode that frightened or upset them or the people around them. Some have already been to their GP and left with an antidepressant prescription and a sense that something was missed. Some have been told it is stress, or anxiety, or "just how things are at this stage of life."

It is not just how things are. It has a cause, and it has a treatment.

What is menopause rage, and is it different from ordinary anger?

Menopause rage is the term used to describe episodes of intense anger and irritability that are disproportionate in scale to their trigger, feel difficult to control, and are directly linked to the hormonal changes of perimenopause and menopause.

It differs from ordinary anger in a specific way: ordinary anger is primarily a response to circumstances. Menopause rage has a second driver beneath the surface, a neurological hair-trigger created by the hormonal disruption of the brain's own mood-regulation systems. The trigger might be real. The intensity of the response is being amplified by something biological happening in your brain.

A 2025 review in Therapeutic Advances in Psychopharmacology by Deshpande and Rao describes a biopsychosocial model of menopause mood changes, in which hormonal, psychological and sociocultural factors interact. The anger is not purely biological, and it is not purely situational. It is both at once, which is part of why it can feel so hard to make sense of.

The brain chemistry behind it: what oestrogen actually does

This matters, because understanding the mechanism is often the first thing that allows women to stop blaming themselves.

Oestrogen is not just a reproductive hormone. It acts directly on the brain, influencing the systems that regulate mood, emotional response, and stress tolerance. Specifically, oestrogen supports the production and activity of serotonin (which stabilises mood), GABA (the brain's main inhibitory neurotransmitter, which acts as a calming signal), and dopamine (which drives motivation and emotional reward). Oestrogen also supports the prefrontal cortex in its regulation of another part of the brain called the amygdala, which is responsible for threat detection and the "fight or flight" response.

In simple terms: when oestrogen is adequate and stable, the brain's emotional brake system works. The prefrontal cortex keeps the amygdala's alarm response proportionate. When oestrogen fluctuates erratically, as it does during perimenopause, or declines significantly, as it does at menopause, those brakes weaken. The amygdala becomes more reactive causing the threshold for anger, fear, and overwhelm to drop.

A 2024 narrative review published in Maturitas by Fidecicchi and colleagues describes this as a disruption of the balance between excitatory and inhibitory inputs in the central nervous system, generating mood instability, irritability, and anger as a direct neurological consequence of hormonal change.

The anger you are experiencing is not a symptom of emotional weakness or poor coping. It is the response of a brain whose regulatory systems have been destabilised.

It is not just your hormones: the double burden

It is important to understand that the biological mechanism is only one part of the picture. The other part is the situation or circumstances in which women find themselves when these symptoms surface.

You are likely sleeping badly, because night sweats are disrupting your rest. You may be managing caring responsibilities for children, for ageing parents, and often its both. You may be navigating a career at a point of significant pressure and responsibility. You may have already tried to talk to your GP about your symptoms and left feeling dismissed or only partially heard. You may have been told your blood tests were "normal" and sent away without an explanation, let alone treatment. You may have been prescribed antidepressants for what you suspected was something hormonal.

“The anger you feel is a product of your changing hormone levels. However, for many women, it is also an entirely appropriate response to a healthcare system that has historically dismissed menopause symptoms, a culture that has kept menopause invisible, and the accumulated weight of being expected to keep functioning at full capacity while quietly experiencing a significant neurological and hormonal disruption.”

Katy Jackson, Clinical Director - Women's Health

The biopsychosocial review by Deshpande and Rao highlights this exact point: sociocultural factors, including gender inequality, ageism, and the societal invisibility of menopause, interact with the biological and psychological dimensions of mood change to amplify the overall experience. The anger is real on every level.

Understanding the biological and psychosocial origins of your anger should not be a reason to avoid treatment. It should empower you to seek it, and to seek a quality of care that addresses the full picture.

The antidepressant problem

One of the most common experiences for women researching this topic is being prescribed antidepressants by a GP without a prior conversation about hormones.

This happens for understandable reasons. Low mood, anxiety, irritability, and poor sleep are symptoms that map onto depression as well as onto perimenopause. GPs working under intense time pressure often have to make quick assessments without the full picture to hand. And antidepressants are a tool many GPs know well and feel more comfortable prescribing under those circumstances.

But NICE guidance (NG23) specifically advises that HRT should be considered for perimenopausal women with low mood or anxiety, and that antidepressants should not be offered as a first-line treatment unless there is also a diagnosed depressive disorder or relevant mental health history. In other words, treating mood symptoms in this patient group with antidepressants, without acknowledging the underlying hormonal influence, means treating symptoms and not the root cause.

A cohort study of 978 women published in BJPsych Open by Reisel and colleagues found that irritability was the fourth most prevalent symptom in women attending a UK specialist menopause clinic, reported by 90% of participants, ranking above hot flushes. All mood symptoms improved significantly after three months of HRT, with or without testosterone.

If you have been prescribed antidepressants for mood symptoms and a conversation about hormones has not happened, it is worth asking for that conversation. This is not a suggestion to stop any medication without medical guidance, but it is a suggestion to ensure you have had the full assessment you are entitled to, including a discussion of whether hormonal treatment might be more appropriate for you.

How long does menopause rage last?

The honest answer is: it depends significantly on whether and when treatment begins.

Anger and irritability tend to be at their most intense during perimenopause, when oestrogen fluctuates erratically rather than declining smoothly. This volatile pattern is what most destabilises the brain's regulatory systems. After menopause, when oestrogen reaches a new (low but stable) baseline, some women find mood symptoms ease naturally. Others do not.

Without treatment, perimenopause can last between four and ten years. The Reisel et al. cohort study found that all mood symptoms, including irritability, improved significantly after three months of HRT. This does not mean every woman will see full resolution within three months, and it is important to approach timelines as population-level data rather than individual predictions. But it does mean that for most women, effective treatment produces meaningful improvement within weeks to months, rather than years.

Waiting it out is a valid choice for some women. But it is worth knowing that you are not obligated to wait.

What actually helps: the evidence

Body identical HRT

HRT, specifically transdermal oestradiol with micronised progesterone, is the most effective treatment for mood symptoms driven by hormonal change. It addresses the root cause by restoring the oestrogen that regulates serotonin, GABA, and prefrontal cortex function.

A landmark randomised controlled trial published in JAMA Psychiatry by Gordon and colleagues (2018) found that transdermal oestradiol with intermittent micronised progesterone significantly prevented the onset of clinically significant depressive symptoms during the menopausal transition. In the treatment group, 17.3% developed significant depressive symptoms, compared to 32.3% in the placebo group.

More recently, a retrospective cohort study published in the British Journal of Psychiatry by Glynne and colleagues (2025), involving 920 women at a UK specialist menopause clinic, found a 44.6% mean reduction in mood symptoms after an average of 107 days on transdermal oestradiol with micronised progesterone. This is the most contemporary and UK-specific evidence available for HRT's effect on emotional symptoms. It is not an RCT, but it is a large real-world dataset and the effect size is clinically meaningful.

Across Voy members receiving menopause treatment, 83% reported improved mood and emotional symptoms, and 88% felt more hormonally balanced at three months, compared to 62% receiving standard care.

As with all HRT decisions, the benefit-risk profile is individual. A BMS-trained specialist will assess your personal and family history before recommending a specific formulation and dose.

Testosterone for mood and energy

Testosterone is often associated with libido, but it plays an important role in women's mood, energy, motivation, and emotional resilience. Levels decline during menopause, and this decline contributes to the fatigue and emotional flatness that frequently accompanies, and amplifies, the anger and irritability.

The Glynne et al. 2025 study specifically included a testosterone arm. Adding testosterone to oestradiol and progesterone produced additional mood benefits for a significant subset of women. Testosterone replacement is part of Voy's menopause service and is considered where clinically appropriate during your specialist consultation.

CBT: the evidence-based talking therapy option

CBT (Cognitive Behavioural Therapy), a structured talking therapy, has a strong evidence base for reducing the psychological burden of menopause symptoms, including mood symptoms, in women who cannot or choose not to use HRT, as well as alongside hormonal treatment.

A systematic review and meta-analysis published in BJOG by Driel and colleagues (2019) reviewed RCT evidence and found that CBT and mindfulness-based therapies significantly reduce the psychological impact of menopausal symptoms. For mood and irritability specifically, CBT works by addressing the cognitive patterns that amplify the emotional response: the anticipatory anxiety, the catastrophising, and the helplessness that accumulate when symptoms are not adequately treated.

Voy offers CBT as part of its menopause service, alongside HRT and other treatment options.

Lifestyle foundations: useful, but realistic

Sleep, exercise, reduced alcohol, and stress management all support mood stability. This is not nothing. But they must be framed honestly: lifestyle measures reduce the burden of symptoms at the margins. They are not a substitute for clinical treatment when symptoms are significantly affecting your life or relationships.

If you are sleeping badly because of night sweats, addressing the night sweats through treatment is more likely to improve your mood than any number of sleep hygiene interventions applied on top of an untreated hormonal disruption.

When to talk to someone today

If menopause rage is affecting your closest relationships, your ability to function at work, or your sense of who you are, that is sufficient reason to seek specialist care now rather than waiting to see if things improve.

Beyond the day-to-day impact, it is important to name something that is not discussed enough: menopause mood symptoms can become severe. A cohort study published in BJPsych Open involving 1,212 women at a UK specialist menopause clinic found that 98% reported mood and mental health symptoms at baseline, and one in six reported thoughts of self-harm prior to initiating HRT.

This alarming figure reflects the real severity that menopause mood symptoms can reach, and women in that position deserve to know that this is a recognised clinical reality, not a personal failing, and that effective treatment exists.

If you are having thoughts of harming yourself, please reach out for support today. The Samaritans are available 24 hours a day on 116 123, and your GP can refer you urgently to mental health support. You do not have to manage this alone.

For women whose symptoms are affecting daily life without reaching that level of severity, a Voy menopause consultation is a practical and appropriate next step. Your consultation is 45 minutes with a BMS-trained menopause specialist, allowing them to take a proper history, understand the full picture of your symptoms, and build a treatment plan that addresses the underlying cause rather than the surface presentation.

93% of Voy members reported an improvement in overall quality of life following treatment. That improvement includes mood, sleep, energy, and the ability to feel like yourself again.

If you are in crisis or having thoughts of self-harm, contact the Samaritans on 116 123 (free, 24 hours) or visit your nearest A&E.

Not sure what’s normal anymore?
When you're experiencing new symptoms, it can be hard to know what’s part of menopause and what’s not. You deserve care that looks at the full picture.

FAQ

DisclaimerAt Voy, we ensure that everything you read in our blog is medically reviewed and approved. However, the information provided is not meant to replace professional medical advice, diagnosis, or treatment. It should not be relied upon for specific medical advice.
References
icon¹

Fidecicchi T, Giannini A, Chedraui P, et al. Neuroendocrine mechanisms of mood disorders during menopause transition: a narrative review and future perspectives. Maturitas, 2024. https://doi.org/10.1016/j.maturitas.2024.108087

icon²

Glynne S, Kamal A, McColl L, et al. Transdermal oestradiol and testosterone therapy for menopausal depression and mood symptoms: retrospective cohort study. British Journal of Psychiatry, 2025. https://pubmed.ncbi.nlm.nih.gov/40519046/

icon³

Reisel D, Crockett C, Glynne S, et al. Prevalence of cognitive and mood-related symptoms in a large cohort of perimenopausal and menopausal women. BJPsych Open, 2024. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11738833/

Relief starts here. Answer a few questions to see how Voy can help you.